GenVivo develops innovative gene therapies to treat cancer and prolong patient survival while improving quality of life.
Our approach to synergistically kill tumors while activating the immune system to fight the patient’s cancer, combined with the integration of novel companion diagnostics positions us on the cutting edge of cancer immunotherapies and emerging clinical-stage cancer companies.
We are an ambitious, growing company whose employees are enthusiastic and passionate, respectful of each other, and highly committed to our mission and values.
The company thrives on collaboration and since we are currently small, every individual and each idea is important and counts.
Developing revolutionary gene therapies for a healthy and happy world.
Enabling access to innovative treatment options for patients in need of effective medical solutions.